Navigation Links
Baxa Corporation Launches 'Culture of Safety' Campaign to Recognize National Patient Safety Awareness Week
Date:3/10/2009

New campaign targets push towards cultural changes that promote patient safety.

ENGLEWOOD, Colo., March 10 /PRNewswire/ -- Baxa Corporation, a leading developer of technology for the safe handling, packaging and administration of fluid medications, announces the launch of a targeted campaign recognizing patient safety. The year-long "Culture of Safety" campaign is intended to emphasize the need for a true cultural change in attitudes and practices geared towards patient and medication safety. The campaign is timed to launch during National Patient Safety Awareness Week, which targets both pharmacy and nursing staff in US hospitals.

"Baxa intends to play a leading role as a change agent where both patient and medication safety is concerned," says Greg Baldwin, Chairman and CEO. "In difficult economic times, budgets and services can be reduced or eliminated - making it more important than ever to help bring patient safety awareness levels up," says Baldwin. Baxa provides devices and systems that improve pharmacy productivity and provide solutions for enhancing patient safety, and reducing the opportunity for medication errors.

National Patient Safety Awareness Week, organized by The National Patient Safety Foundation, is held annually and designed to engage staff, patients and community by emphasizing the critical need for partnership and participation in the drive for a safer healthcare system. Programs that highlight new methods for improving the information exchange that occurs during patient-provider encounters will be launched and promoted during the course of the week.

One of the ways that Baxa is bringing patient safety to a new level is through its Abacus(TM) Order Entry and Calculation Software. Through customer feedback and experience with the program, Baxa determined that establishing appropriate warning limits could reduce an element of risk with the highly configurable software. Without impacting the flexibility of the program to meet facility-specific compounding requirements, Baxa was able to offer guidelines for the use of its Abacus Software that improve patient safety by limiting the opportunity for catastrophic errors and enhance the function of the program through greater use of templates. One of the components of the Baxa campaign is to offer free white papers detailing customer experiences with the Abacus tool and how the new warning limits have helped facilities avoid medication errors and have positive patient outcomes.

Other 2009 Culture of Safety initiatives include targeted email campaigns, sponsorship of speakers at industry meetings and case studies geared towards patient and medication safety improvements.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at www.baxa.com.

About the National Patient Safety Foundation

The National Patient Safety Foundation is an independent not-for-profit 501(c)(3) organization that has been diligently pursuing one mission since its founding in 1997 - to improve the safety of patients. NPSF also occupies a unique position by virtue of its inclusive, multi-stakeholder approach, which fosters collaboration on the issue of patient safety. More information is available at www.npsf.org.

    Contact:
    Marian Robinson, Vice President, Marketing
    Baxa Corporation:  800.567.2292 ext. 2157 or 303.617.2157
    Email:  marian.robinson@baxa.com

    Maggie Chamberlin Holben, APR
    Absolutely Public Relations: 303.984.9801 or 303.669.3558
    Email: maggie@absolutelypr.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CompuCyte Corporation and Program in Cellular and Molecular Medicine at Childrens Hospital Boston Announce Joint Program for Quantitative Imaging Cytometry Research Services
2. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
3. Providence Service Corporation to Report Fourth Quarter and Year End 2008 Results on Monday, March 16th Before the Market Opens
4. Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
5. Santa Monica Media Corporation Files Extension Proxy With SEC to Complete Transaction
6. Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31, 2008 Results
7. Sysmex Corporation Announces Organizational Changes
8. Digirad Corporation Sells Arizona, Nevada Service Hubs
9. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
10. CVS Caremark Corporation Announces Quarterly Dividend
11. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology: